pre-seed
Stage
1
Investors
About
Noscendo GmbH develops DISQVER, a CE- and IVDR-marked diagnostic software platform for clinical diagnostics and pathogen detection that provides physicians and medical laboratories with diagnostic decision support; the company lists certifications including ISO 13485, ISO 27001 and HIPAA compliance.
Explore Noscendo's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.